Author:
Feinberg Bruce A.,Jolly Pradeep,Wang Si-Tien,Fortner Barry,Scott Jeffrey,Gilmore James,Neary Maureen P.,Duh Mei Sheng
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference17 articles.
1. Rohrmann K, Staehler M, Haseke N, et al. Immunotherapy in metastatic renal cell carcinoma. World J Urol. 2005;23:196–201.
2. Parmar S, Rademaker AW, Fung BB, et al. High dose IL-2 is associated with durable disease free survival and clinically important improvement in overall survival in metastatic renal cell cancer. Proc Am Soc Clin Oncol 2003;22:(abstr 1630).
3. Motzer RJ, Mazumdar M, Bacik J, et al. Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma. J Clin Oncol. 2000;18:1928–35.
4. Haferkamp A, Hofenfellner M. Medical treatment options in patients with metastatic renal cell carcinoma. Nephrol Dial Transplant. 2007;22:996–9.
5. Kapoor A, Figlin R. Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma. Cancer. 2009;115:3618–30.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献